Entities / Entity
Center for Biologics Evaluation and Research.
FDA research center
- Reports this week
- 0
- Active events
- 0
- Connections
- 14
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
No events began in the chosen period. Widen it, or reset.
Around Center for Biologics Evaluation and Research this week
News at the entities that move Center for Biologics Evaluation and Research most-
FDA StructuralFDA rated generic equivalent to brand Climara Pro.Moves Center for Biologics Evaluation and Research
-
Marty Makary StructuralPresley Gerber posted about Ibogaine on Instagram while Marty Makary advised the FDA on drug approval potential amid an executive order fast-tracking psychedelic research.Moves Center for Biologics Evaluation and Research
-
Teleflex Shared contextTeleflex and Trinity Biotech are being compared as healthcare companies.Moves Center for Biologics Evaluation and Research
Connections
The 3 strongest of 14, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
CBER is a specialized research center that operates as a division under the authority of the FDA.
-
Marty Makary Structural
Marty Makary holds a permanent director role at the Center for Biologics Evaluation and Research.
-
Teleflex Shared context
CBER operates as a regulatory body within the market context of Teleflex.